middle.news
OncoSil clears key quality hurdle for Sydney manufacturing facility
8:43am on Wednesday 9th of September, 2026 AEST
•
Medical Devices
Read Story
OncoSil clears key quality hurdle for Sydney manufacturing facility
8:43am on Wednesday 9th of September, 2026 AEST
Key Points
Cyclotek receives ISO 13485 medical-device quality certification
Macquarie Park site still requires Notified Body approval
Production targeted by the end of 2Q FY27
Facility designed for higher capacity and less than 5% capital intensity at full capacity
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE